Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec;48(12):1785-1792.
doi: 10.1038/s41366-024-01628-x. Epub 2024 Sep 14.

Body mass index changes and their association with SARS-CoV-2 infection: a real-world analysis

Affiliations

Body mass index changes and their association with SARS-CoV-2 infection: a real-world analysis

Jithin Sam Varghese et al. Int J Obes (Lond). 2024 Dec.

Abstract

Objective: To study body mass index (BMI) changes among individuals aged 18-99 years with and without SARS-CoV-2 infection.

Subjects/methods: Using real-world data from the OneFlorida+ Clinical Research Network of the National Patient-Centered Clinical Research Network, we compared changes over time in BMI in an Exposed cohort (positive SARS-CoV-2 test between March 2020-January 2022), to a contemporary Unexposed cohort (negative SARS-CoV-2 tests), and an age/sex-matched Historical control cohort (March 2018-January 2020). BMI (kg/m2) was retrieved from objective measures of height and weight in electronic health records. We used target trial approaches to estimate BMI at start of follow-up and change per 100 days of follow-up for Unexposed and Historical cohorts relative to the Exposed cohort by categories of sex, race & ethnicity, age, and hospitalization status.

Results: The study sample consisted of 249,743 participants (19.2% Exposed, 61.5% Unexposed, 19.3% Historical cohort) of whom 62% were women, 21.5% Non-Hispanic Black, 21.4% Hispanic and 5.6% Non-Hispanic other and had an average age of 51.9 years (SD: 18.9). At start of follow-up, relative to the Unexposed cohort (mean BMI: 29.3 kg/m2 [95% CI: 29.1, 29.4]), the Exposed (0.07 kg/m2 [95% CI; 0.01, 0.12]) had higher mean BMI and Historical controls (-0.20 kg/m2 [95% CI; -0.25, -0.15]) had lower mean BMI. Over 100 days, BMI did not change (0 kg/m2 [95% CI: -0.03, 0.03]) for the Exposed cohort, decreased (-0.04 kg/m2 [95% CI; -0.05, -0.02]) for the Unexposed cohort and increased (0.03 kg/m2 [95% CI; 0.01, 0.04]) for the Historical cohort. Observed differences in BMI at start of follow-up and over 100 days were consistent between Unexposed and Exposed cohorts for most subgroups, except at start of follow-up period among Males and those 65 years or older who had lower BMI among Exposed.

Conclusions: In a diverse real-world cohort of adults, mean BMI of those with and without SARS-CoV2 infection varied in their trajectories. The mechanisms and implications of weight retention following SARS-CoV-2 infection remain unclear.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no competing interests. Ethics approval and consent to participate: The Institutional Review Board of Emory University determined the study (IRB ID: STUDY00004932) met criteria for exemption under 45 CFR 46.104(d). This study followed the REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement [36]. All methods were performed in accordance with relevant guidelines and regulations. The research involved no more than minimal risk, could not be practicably carried out without waiver of informed consent, and does not involve identifiable private information of included individuals.

Figures

Figure 1
Figure 1
All estimates are from the marginal structural model with statistical interaction of exposure group, effect modifier (i.e., sex, age, race-ethnicity, hospitalization status) and time. Associations are adjusted for BMI closest to index date during lookback period and any imbalanced covariates. Associations reported above are also available in Supplementary Table 5. Our historical cohort corresponds with the blue lines. Our unexposed cohort corresponds with the green lines. Our exposed cohort corresponds with the red lines. Panel A: Difference relative to Exposed cohort at start of follow-up. Panel B: Difference relative to Exposed cohort per 100 days of follow-up.

Update of

References

    1. Singh AK, Khunti K. COVID-19 and Diabetes. Annu Rev Med. 2022;73(1):129–147. doi: 10.1146/annurev-med-042220-011857 - DOI - PubMed
    1. Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. The Lancet Diabetes & Endocrinology. 2022;10(5):311–321. doi: 10.1016/S2213-8587(22)00044-4 - DOI - PMC - PubMed
    1. Barrett CE, Koyama AK, Alvarez P, Chow W, Lundeen EA, Perrine CG, et al. Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years — United States, March 1, 2020–June 28, 2021. MMWR Morb Mortal Wkly Rep. 2022;71(2):59–65. doi: 10.15585/mmwr.mm7102e2 - DOI - PMC - PubMed
    1. Rathmann W, Kuss O, Kostev K. Incidence of newly diagnosed diabetes after Covid-19. Diabetologia. Published online March 16, 2022. doi: 10.1007/s00125-022-05670-0 - DOI - PMC - PubMed
    1. Holman N, Barron E, Young B, Gregg EW, Khunti K, Valabhji J, et al. Comparative Incidence of Diabetes Following Hospital Admission for COVID-19 and Pneumonia: A Cohort Study. Diabetes Care. 2023;46(5):938–943. doi: 10.2337/dc22-0670 - DOI - PubMed

Publication types